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Background: GABAA receptors are ligand-gated Cl
- channels, and the intracellular Cl- concentration governs
whether GABA function is excitatory or inhibitory. During early brain development, GABA undergoes functional
switch from excitation to inhibition: GABA depolarizes immature neurons but hyperpolarizes mature neurons due to
a developmental decrease of intracellular Cl- concentration. This GABA functional switch is mainly mediated by the
up-regulation of KCC2, a potassium-chloride cotransporter that pumps Cl- outside neurons. However, the upstream
factor that regulates KCC2 expression is unclear.
Results: We report here that KCC2 is unexpectedly regulated by neuroligin-2 (NL2), a cell adhesion molecule
specifically localized at GABAergic synapses. The expression of NL2 precedes that of KCC2 in early postnatal
development. Upon knockdown of NL2, the expression level of KCC2 is significantly decreased, and GABA functional
switch is significantly delayed during early development. Overexpression of shRNA-proof NL2 rescues both KCC2
reduction and delayed GABA functional switch induced by NL2 shRNAs. Moreover, NL2 appears to be required to
maintain GABA inhibitory function even in mature neurons, because knockdown NL2 reverses GABA action to
excitatory. Gramicidin-perforated patch clamp recordings confirm that NL2 directly regulates the GABA equilibrium
potential. We further demonstrate that knockdown of NL2 decreases dendritic spines through down-regulating KCC2.
Conclusions: Our data suggest that in addition to its conventional role as a cell adhesion molecule to regulate
GABAergic synaptogenesis, NL2 also regulates KCC2 to modulate GABA functional switch and even glutamatergic
synapses. Therefore, NL2 may serve as a master regulator in balancing excitation and inhibition in the brain.
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A delicate balance between excitatory and inhibitory
neurotransmission is critical for brain functions. GABA is
the principle inhibitory neurotransmitter in the adult
brain, and dysfunction of GABAergic transmission may
contribute to the onset of many neurological disorders
including epilepsy, schizophrenia, autism spectrum disor-
ders, and major depressive disorders [1-3]. Because
GABAA receptors are ligand-gated Cl
- channels, the effi-
cacy of GABAergic transmission is modulated by changes
in intracellular Cl- concentration. Two chloride trans-
porters, NKCC1 and KCC2, import and export Cl- across
neuronal membranes correspondingly. In early neural de-
velopment, the expression level of NKCC1 is initially high* Correspondence: gongchen@psu.edu
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reproduction in any medium, provided the orand gradually down-regulated, while KCC2 expression
is up-regulated [4,5]. Such developmental changes of
NKCC1 and KCC2 result in a shift of intracellular Cl- con-
centration from high to low and a corresponding shift of
GABAA receptor reversal potential from depolarizing to
hyperpolarizing [6,7]. Therefore, GABA is not a simple in-
hibitory neurotransmitter, but rather undergoes a func-
tional switch from excitation to inhibition during brain
development. GABA-mediated excitation regulates neural
differentiation, migration, and synaptogenesis [4,8-10].
Our previous work found that GABAergic synaptogenesis
precedes glutamatergic synaptogenesis due to the earlier
expression of GABAA receptors than that of glutamate re-
ceptors in embryonic neurons [11]. So far, it is unclear
whether there is any coordination between GABA func-
tional switch and GABAergic synapse formation.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sion molecules that interact with presynaptic neurexins
[12]. NL1 and NL2 are selectively localized at glutamatergic
and GABAergic synapses [13,14], and manipulations of
NL1 and NL2 expression level have been shown to regulate
glutamatergic and GABAergic synaptogenesis, respectively
[15-17]. Transgenic mice overexpressing NL2 showed en-
hanced GABAergic transmission [18], whereas NL2 knock-
out mice showed decreased GABAergic transmission [19].
We have previously shown that NL2 is a critical cell adhe-
sion molecule capable of inducing functional GABAergic
synapses in neuron-HEK cell hetero-cocultures [20]. Our
recent work further identified a loss-of-function mutation
of NL2 in schizophrenia patients [21], suggesting an indis-
pensable role of NL2 in regulating GABAergic functions.
Here, we uncover a novel function of NL2 in regulating
KCC2 expression and GABA functional switch from exci-
tation to inhibition during neurodevelopment. Knock-
down of NL2 also induces an unexpected reduction in
glutamatergic events and dendritic spines. Therefore, in
addition to its role as a cell adhesion molecule at
GABAergic synapses, NL2 may serve as a master regulator
of the delicate balance between glutamatergic and
GABAergic functions in neural networks.
Results
Neuroligin-2 unexpectedly regulates KCC2 expression
Neuroligin-2 (NL2) is a cell adhesion molecule mainly
localized at GABAergic synapses [14]. We have previ-
ously demonstrated that overexpression of NL2 and
GABAA receptors in HEK cells can induce fully func-
tional GABAergic synapses when cocultured with neu-
rons [20]. Recently we also identified a mutant NL2
from human schizophrenia patient that is defective in
promoting GABAergic synapse formation [21]. During
our continued study of NL2 in synapse formation and
plasticity, we made an unexpected finding that NL2 reg-
ulates KCC2, a K+-Cl- cotransporter that is critical in
controlling intracellular Cl- concentration and the polar-
ity of GABA action. We investigated the function of
NL2 by using small-hairpin RNA (shRNA) mediated
knockdown in cultured mouse cortical neurons. Two
previously well characterized shRNAs were used to
knockdown NL2 expression level: one is a chained shRNA
targeting all NL1-3 (NLmiR) [22] and the other is a NL2-
specific shRNA (NL2shRNA) [15]. When HA-tagged wild
type (WT) NL2 was coexpressed with NL2shRNA or
NLmiR, the expression level of HA-NL2 was reduced by
more than 80% compared to the coexpression with mCherry
alone as a control (Figure 1A, quantified in Figure 1C left
columns). In contrast, the expression of a shRNA-proof mu-
tant version of NL2 (HA-NL2*) [22] was not affected by
NL2shRNA or NLmiR (Figure 1B, quantified in Figure 1C
right columns). Therefore, both NLmiR and NL2shRNAcan efficiently knockdown NL2, and the mutant NL2* was
suitable for rescue experiments.
When we transfected mouse cortical neurons with
NLmiR, we observed a significant reduction of the
KCC2 expression level compared to that of non-
transfected (nonTF) or mCherry-transfected control
neurons (Figure 1D, quantified in Figure 1G). This is un-
expected because no previous study reported any con-
nection between NL2 and KCC2. To find out the
relative contribution of NL1 versus NL2 to the reduced
KCC2 expression, shRNA-proof HA-NL1* or HA-NL2*
was coexpressed with NLmiR to test which one can res-
cue the KCC2 expression. HA-immunostaining confirmed
the expression of shRNA-proof NL1* and NL2* in the
presence of NLmiR (Figure 1E inlets). Coexpression of
HA-NL2*, but not HA-NL1*, with NLmiR significantly
rescued the KCC2 expression level (Figure 1E, quantified
in Figure 1G), suggesting that NL2 is a potential regulator
of KCC2. This was confirmed by the detection of a similar
reduction of KCC2 level after knocking down NL2 specif-
ically with NL2shRNA (Figure 1F, quantified in Figure 1G).
One concern regarding shRNAs is whether they might
have off-target effect directly on KCC2. To exclude this
possibility, we co-transfected NL2shRNA together with
KCC2 in HEK 293T cells to examine whether KCC2 ex-
pression might be altered. Immunoblot demonstrated that
while WT NL2 expression was significantly reduced by
NL2shRNA (Figure 1H, top panel), KCC2 expression was
not affected by NL2shRNA (Figure 1H, bottom panel).
We next examined the effect of NL2shRNA on NKCC1,
which imports Cl- and counteracts the action of KCC2
[7]. Immunostaining with antibody specific for NKCC1
showed that NL2 knockdown did not change NKCC1 ex-
pression level (Figure 1I). Together, our data demon-
strated a novel function of NL2 in regulating KCC2, both
of which were found previously playing critical roles in
GABA function but not yet linked together.
Neuroligin-2 regulates GABA excitation-inhibition switch
KCC2 is a key player in controlling intracellular Cl- con-
centration and driving GABA functional switch from ex-
citation to inhibition during early development [23,24].
Therefore, if KCC2 is regulated by NL2, we predict that
GABA functional switch might be affected accordingly.
To test this hypothesis, cortical neurons were co-
transfected at 2 DIV by mCherry with NLmiR, and
Fura-2 Ca2+ ratio imaging was employed to monitor
GABA-evoked Ca2+ influx to determine whether GABA
action is excitatory or inhibitory [25]. When neurons were
analyzed 6 days later (at 8 DIV), we found that GABA
(100 μM) application evoked small Ca2+ responses in less
than 50% of non-transfected control neurons but large
Ca2+ responses in over 90% of NLmiR-transfected neurons
(Figure 2A-B). As a control, high potassium (90 mM)
Figure 1 Knockdown of neuroligin-2 decreases KCC2 expression. A, Efficient knockdown of NL2 by NL2shRNA or NLmiR in mouse cortical
neurons. Neurons were co-transfected with mCherry at 2 DIV and HA-NL2 expression was assayed by HA-immunostaining at 8 DIV. B,
shRNA-proof mutant HA-NL2* was resistant to the knockdown of NL2shRNA or NLmiR. Scale bar, 10 μm. C, Bar graphs showing quantified
somatic HA-immunostaining intensity (normalized by mCherry controls). ***p < 0.001 (one-way ANOVA). D, Representative images showing
reduced KCC2 immunostaining (green) in NLmiR-transfected neurons (arrowhead) compared to non-transfected neurons (arrow, 12 DIV). Scale
bar, 20 μm. E, NL2*, but not NL1* rescued the KCC2 level when coexpressed with NLmiR. Inlets showed HA-immunostaining (gray) to confirm the
expression of HA-NL1* and HA-NL2*. Scale bar, 20 μm. F, NL2shRNA also decreased KCC2 expression level. Scale bar, 20 μm. G, Bar graphs
showing quantified somatic KCC2 immunofluorescence intensity in non-transfected (nonTF) neurons (173 ± 4 a.u.) and neurons transfected with
mCherry (172 ± 10), NLmiR (73 ± 8), NLmiR + NL1* (93 ± 9), NLmiR + NL2* (120 ± 12), or NL2shRNA (80 ± 11). a.u., arbitrary unit. **p < 0.01,
***p < 0.001, n.s., not significant, one-way ANOVA. H, NL2shRNA specifically knock down NL2 but not KCC2 in HEK 293T cells, which were
co-transfected with NL2 + GFP, NL2 + NL2shRNA, KCC2 + GFP, or KCC2 + NL2shRNA. Total protein lysate was analyzed by immunoblot. Actin was
used as loading control. I, NKCC1 immunostaining signal (red) was not altered in NL2shRNA-transfected neurons (green, arrowhead, 9 DIV). Scale
bar, 20 μm. Bar graphs show the quantified somatic NKCC1 signal intensity (p > 0.7, unpaired Student’s t-test).
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transfected and NLmiR-transfected neurons (Figure 2B).
GABA-evoked Ca2+ increase was completely blocked by
GABAA receptor antagonist bicuculline (BIC, 20 μM)
(Figure 2C), suggesting that Ca2+ influx was mediated by
GABAA receptor activation.
Using Ca2+ imaging approach, we further delineated
the time course of GABA functional switch by monitor-
ing the gradual decrease of GABA-evoked Ca2+ re-
sponses in developing neurons. We found that mouse
cortical neurons typically complete their GABA func-
tional switch around two weeks in dissociated cultures
(Figure 2D), similar to previous reports [26,27]. Quanti-
tatively, for control neurons transfected with mCherry,
GABA evoked Ca2+ responses in 80 ± 5% (n = 96)
neurons at 4 DIV, but only 8 ± 3% (n = 61) at 12 DIV
(Figure 2D), suggesting that the majority of neuronshave finished the GABA excitation-inhibition transi-
tion by 12 DIV. However, after NL knockdown, even
at 12 DIV, GABA still evoked Ca2+ responses in more
than 80% of transfected neurons (Figure 2D; NLmiR,
86 ± 5%, n = 86; NL2shRNA, 86 ± 8%, n = 41; p < 0.001
for transfection of mCherry vs. NLmiR or NL2shRNA,
two-way ANOVA). Importantly, coexpression of NLmiR
with NL2*, but not NL1*, promoted GABA functional
switch by 12 DIV (Figure 2D; NLmiR vs. NLmiR+NL2*,
p < 0.001, one-way ANOVA at 12 DIV), suggesting that
NL2 may regulate GABA excitation-inhibition switch.
Besides quantifying the percentage of neurons responding
to GABA, we also compared the amplitude of GABA-
evoked Ca2+ responses in individual neurons. At 4 DIV,
most neurons in all groups showed significant GABA-
evoked Ca2+ responses, suggesting an excitatory action of
GABA (Figure 2E). At 12 DIV, while control neurons
Figure 2 Knockdown of neuroligin-2 abolishes GABA functional switch in cortical neurons. A, Representative images showing 8 DIV
NLmiR-transfected neurons loaded with Fura-2. Somata of both nonTF and transfected neurons were selected (Fura-2 panel, white circles) to
measure 340/380 ratio signal. Scale bar, 40 μm. B, Sample traces showing somatic Ca2+ responses after stimulation with 100 μM GABA and 90
mM KCl in nonTF neurons (gray, 8 DIV) and NLmiR-transfected neurons (black). C, Averaged sample traces showing that BIC (20 μM) blocked
GABA-evoked Ca2+ responses in both nonTF (gray, n = 6) and NLmiR-transfected neurons (black, n = 17). D, The time courses of GABA functional
switch in nonTF neurons and neurons transfected with mCherry, NLmiR, NLmiR + NL1*, NLmiR + NL2*, or NL2shRNA (3–4 independent cultures;
n = 2291, 272, 433, 350, 322, 152 neurons, respectively). E, Bar graphs showing the amplitude of GABA-evoked Ca2+ increases in neurons
transfected with mCherry, NLmiR, NLmiR + NL1*, NLmiR + NL2*, or NL2shRNA at 4 and 12 DIV. There was no difference between all groups at 4
DIV (p > 0.6). ***p < 0.001, one-way ANOVA. F, Percentage of mature neurons showing GABA-evoked Ca2+ increase after NLmiR or NL2shRNA
transfection. Arrows in D and F indicate the time of transfection (TF).
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sponses, neurons transfected with NLmiR or NL2shRNA
still showed large GABA-evoked Ca2+ responses with the
amplitudes similar to those at 4 DIV (Figure 2E), suggesting
no GABA functional switch occurred after knockdown of
NL2. Coexpression of NLmiR with NL2*, but not NL1*,
resulted in significantly smaller GABA-evoked Ca2+ re-
sponses at 12 DIV (Figure 2E), suggesting that NL2
may restore GABA functional switch. Collectively, our
Ca2+ imaging data demonstrate that NL2 plays a crit-
ical role in regulating GABA functional switch during
early development.We further investigated whether NL2 is required for
maintaining GABAergic inhibition in mature neurons
after the completion of GABA functional switch. To ad-
dress this question, we transfected neurons at 12–14
DIV with NLmiR or NL2shRNA and analyzed GABA-
evoked Ca2+ responses at 16 and 21 DIV. Mature neu-
rons in control group rarely showed any GABA-evoked
Ca2+ responses (Figure 2F; non-transfected, only 4 out
264 neurons; mCherry-transfected, 0/7), but more than
50% mature neurons transfected with NLmiR (n = 59)
or NL2shRNA (n = 12) showed significant GABA-
evoked Ca2+ responses (Figure 2F). Therefore, NL2 is
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ture neurons, but also required for the maintenance of
GABA inhibition in mature neurons.
Neuroligin-2 regulates GABA equilibrium potential
The observed KCC2 reduction and large GABA-evoked
Ca2+ responses after NL2 knockdown suggest an excita-
tory action of GABA due to depolarized GABAA recep-
tor reversal potential (EGABA). To directly examine
EGABA, we performed gramicidin-perforated patch clamp
recordings to keep intracellular Cl- intact [26]. In control
neurons at 10–13 DIV, GABA application (40 μM, 50 ms)
typically evoked small depolarizing or hyperpolarizing
membrane potential changes (Figure 3A, top traces). In
contrast, in neurons transfected with NL2shRNA, GABAFigure 3 Neuroligin-2 regulates GABA equilibrium potential. A,
Representative current clamp recordings showing differential
changes in membrane potentials evoked by GABA in 10–13 DIV
control neurons (gray) and NL2shRNA-transfected neurons (black).
Note that GABA evoked action potentials in most NL2shRNA-
transfected neurons (4 out of 5 neurons) but rarely in control
neurons (1/6). B, Representative voltage-clamp recordings showing
GABA-evoked currents at different holding potentials in the
presence of TTX (0.5 μM) and DNQX (10 μM). C, I-V plot of the mean
GABA-evoked peak currents in control neurons and neurons
transfected with NLmiR, NL2shRNA, or NL2. Note the opposite shift
in EGABA between NL2 overexpression and NL2 knockdown groups.
D, Bar graphs showing mean EGABA of control neurons and neurons
transfected with NLmiR, NL2shRNA, or NL2. Dashed line indicates
the mean EGABA of control neurons. *p < 0.05, **p < 0.01,
***p < 0.001, one-way ANOVA.reliably evoked action potentials on top of large depolariz-
ing responses (Figure 3A, bottom traces), confirming that
GABA function remains excitatory after NL2 knockdown.
Changing holding membrane potentials under voltage-
clamp condition revealed a significant depolarizing shift in
EGABA after NL2 knockdown (Figure 3B). Quantitatively,
knockdown of NL2 alone resulted in a depolarizing shift of
16 mV in EGABA and knockdown of NL1-3 induced a shift
of 22 mV (Figure 3C-D; EGABA: Control, -56 ± 3 mV;
NL2shRNA, -40 ± 2 mV; NLmiR, -34 ± 2 mV). Interest-
ingly, overexpression of NL2 caused an opposite change:
a significant hyperpolarizing shift of 12 mV in EGABA
(Figure 3C-D; NL2, -68 ± 3 mV). On the other hand, the
resting membrane potential was not significantly altered by
NL2 manipulations (Control, -60 ± 2 mV; NLmiR, -58 ±
4 mV; NL2shRNA, -63 ± 2 mV; NL2, -67 ± 2 mV; p > 0.08).
These results suggest that NL2 plays an active role in
controlling the functional polarity of GABA action.
Regulation of KCC2 by neuroligin-2 is independent of
GABAA receptor activation and neuronal activity
Since NL2 regulates GABAergic synaptogenesis, we
wondered whether the regulation of KCC2 by NL2
might be mediated by an alteration in GABAA receptor
activation or neuronal activity. To test this idea, cortical
neurons were transfected with NL2shRNA at 2 DIV and
chronically treated for 9 days with BIC (20 μM) to block
GABAA receptors or with tetrodotoxin (TTX, 1 μM)
to block action potential firing. Blocking the activa-
tion of GABAA receptors appeared to have no effect
on the KCC2 level because the neurons transfected
with NL2shRNA still showed a significant reduction of
KCC2 compared to adjacent non-transfected controls
(Figure 4A middle panel, quantified in Figure 4B).
Similarly, inhibiting action potential firing also had no
effect on the reduction of KCC2 induced by NL2 knock-
down (Figure 4A right panel, quantified in Figure 4B).
Therefore, NL2 regulation of KCC2 is not mediated by
GABAA receptors or neuronal activity.
We then investigated whether developmental expression
of KCC2 and NL2 rely upon GABAA receptor activation
or neuronal activity. As expected, KCC2 expression
showed a significant increase from 4 to 12 DIV (Figure 4C
left panel). After chronic treatment with BIC or TTX,
KCC2 level was similarly increased compared to the con-
trol (Figure 4C middle and right panels, quantified in
Figure 4D; n =12 neurons per group; p < 0.001 for de-
velopmental increase; p > 0.5 for drug treatment, Two-
way ANOVA). Immunoblot analysis also found that
NL2 expression level increased significantly from 4 to
12 DIV and were not affected by BIC or TTX treat-
ment (Figure 4E-F; n = 3; p < 0.05 for developmental in-
crease; p > 0.3 for drug treatment, Two-way ANOVA).
Functionally, Ca2+ imaging experiments further showed
Figure 4 Regulation of KCC2 by NL2 is independent of GABAA receptor function or neuronal activity. A, Representative images showing
reduced KCC2 immunostaining (red) in neurons transfected with NL2shRNA (green, arrowheads, 11 DIV), regardless whether treated with BIC or
TTX. DMSO (0.1%, Control), BIC (20 μM) or TTX (1 μM) was added into culture medium after transfection at 2 DIV and replenished every two days.
Scale bar, 20 μm. B, Bar graphs showing somatic KCC2 immunofluorescence intensity in neurons with (+) and without (−) NL2shRNA transfection
(n = 11–12 neurons per group). Cultures were treated with DMSO (Control), BIC or TTX after transfection. ***p < 0.001, unpaired Student’s t-test.
C, Representative images showing MAP2 (green) and KCC2 (red) immunostaining at 4 and 12 DIV in neurons treated with DMSO, BIC or TTX,
starting at 2 DIV. Scale bar, 20 μm. D, Bar graphs showing developmental increase of the somatic KCC2 immunofluorescence intensity
(n = 12 neurons per group). a.u., arbitrary unit. E, Representative immunoblot showing NL2 expression in 4 and 12 DIV neurons treated with
DMSO, BIC or TTX, starting at 2 DIV. Actin was used as loading control. F, Quantification of NL2 expression level as measured by immunoblot
(n = 3 independent cultures). NL2 expression was normalized to the expression level of 4 DIV control. G, Calcium imaging showing the time
courses of GABA functional switch in control neurons and neurons treated with BIC or TTX (3 independent cultures; n = 1141, 717, 737
neurons, respectively).
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between control and BIC- or TTX-treated neurons
(Figure 4G; p > 0.7 for drug treatment, Two-way
ANOVA). Together, our data suggest that the develop-
mental up-regulation of NL2 and KCC2 as well as
GABA functional switch are likely regulated by cell-
intrinsic mechanisms, independent of GABAA receptor
activation or neuronal activity.
Neuroligin-2 expression precedes KCC2 in vivo
We reasoned that if NL2 regulates KCC2, the onset of
NL2 expression should precede that of KCC2. This was
indeed what occurred in the mouse brain in vivo when we
analyzed the time course of the expression of both NL2
and KCC2 from postnatal day 1 to day 20 (Figure 5A-B).
In neonatal mouse brain (P1-P4), NL2 was already
expressed in a significant amount whereas the expression
of KCC2 was minimal, consistent with a delayed KCC2
expression that correlates with GABA functional switch[24]. Quantitatively, NL2 expression at P4 reached about
50% of P20 level, whereas KCC2 did not reach 50% of P20
expression level even at P11 (Figure 5B). Therefore, the
in vivo sequential expression of NL2 and KCC2 makes it
possible for NL2 to regulate KCC2.
We next investigated whether NL2 directly interacts
with KCC2. Because both available NL2 (129203, Synaptic
Systems) and KCC2 (07–432, Millipore) antibodies are
raised in rabbit, it is not feasible to detect endogenous
NL2 and KCC2 simultaneously. Instead, we overexpressed
HA-NL2 in cortical neurons and found partial co-
localization between exogenous HA-NL2 and endogenous
KCC2 (Figure 5C). However, because HA-NL2 was
overexpressed in neurons, it raised a concern whether
HA immunostaining truly represents the endogenous
NL2 localization. We therefore further investigated
possible interaction between NL2 and KCC2 in HEK
293T cells (Figure 5D). As expected, expression of NL2
alone showed mainly membrane localization, and
Figure 5 Neuroligin-2 expression precedes that of KCC2. A,
Representative immunoblot showing the time-course of NL2 and
KCC2 expression in mouse cortex at postnatal day 1 (P1), P4, P8, P11,
P15, and P20. Actin was used as loading control. B, Quantification of
the NL2 and KCC2 expression level as measured by immunoblot
(n = 3). Protein expression was normalized to the expression level at
P20. C, Representative images showing the expression of HA-NL2
(green) and KCC2 (red) in mouse cortical neurons (14 DIV)
transfected with HA-NL2. Empty arrowhead indicates KCC2 puncta
without NL2 colocalization; Filled arrowhead indicates NL2 puncta
without KCC2 colocalization; Arrow indicates colocalized NL2 and
KCC2 puncta. Scale bar, 10 μm. D, Representative images showing
the expression pattern of NL2 (green), KCC2 (red), and NL2 + KCC2
in HEK cells. Scale bar, 10 μm. E, Lack of co-immunoprecipitation
revealed by HEK cells co-transfected with HA-NL2 and KCC2. Total
protein lysate was immunoprecipitated with normal mouse IgG or
mouse anti-HA antibody and immunoblotted with rabbit anti-KCC2
and anti-NL2 antibodies. F, No co-immunoprecipitation detected
between NL2 and KCC2 in mouse brain cortical tissue. Total mouse
cerebral cortex protein lysate was immunoprecipitated with normal
rabbit IgG, rabbit anti-NL2, or rabbit anti-KCC2 antibodies. The
precipitated proteins were then probed with rabbit anti-KCC2 or
anti-NL2 antibodies to test whether
co-immunoprecipitation occurred.
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intracellular localization. Coexpression of NL2 and
KCC2 showed comparable subcellular localization to
that of NL2 or KCC2 expression alone (Figure 5D).
Next, we employed co-immunoprecipitation to exam-
ine whether NL2 and KCC2 interact with each other.
Protein lysate prepared from HEK cells coexpressing
HA-NL2 and KCC2 was immuno-precipitated with
HA antibody. The HA-NL2 was clearly precipitated
but KCC2 was not co-immunoprecipitated (Figure 5E).
We further performed co-immunoprecipitation experiment
using mouse cerebral cortex protein lysate and obtained
similar result to HEK cells that no co-immunoprecipitationcould be detected between NL2 and KCC2, regardless
which protein was immuno-precipitated first (Figure 5F).
These results suggest that NL2 and KCC2 may not directly
interact, or their interaction is too weak to be detected with
current method.
Neuroligin-2 regulates glutamatergic transmission and
dendritic spines through KCC2
Previous study reported that knockdown of NL2 de-
creased not only GABAergic but also glutamatergic syn-
apse numbers [15], but the underlying mechanism was
not well understood. We transfected cortical neurons at
2 DIV with NL2shRNA and employed patch clamp re-
cordings to analyze synaptic events at 10–12 DIV. As
expected, the miniature inhibitory postsynaptic currents
(mIPSCs) were largely abolished in neurons transfected
with NL2shRNA (Figure 6A and C; Control, 0.67 ±
0.25 Hz, n = 10; NL2shRNA, 0.002 ± 0.002 Hz, n = 10;
p < 0.05, unpaired Student’s t-test). Interestingly, the
frequency of miniature excitatory postsynaptic currents
(mEPSCs) was also significantly decreased (Figure 6B-C;
Control, 1.2 ± 0.3 Hz, n = 10; NL2shRNA, 0.01 ± 0.01 Hz,
n = 10; p < 0.01), confirming that NL2 not only regulates
GABAergic synapses, but also affects glutamatergic
synapses. We initially wondered whether the NL2 effect
on glutamatergic synapses might be due to any alterations
of neuronal intrinsic excitability. To test this idea, we
recorded voltage-dependent sodium and potassium
currents but found no difference between control and
NL2shRNA-transfected neurons (Figure 6D-E). Quantita-
tively, the I-V curves of both Na+ and K+ currents showed
no significant difference between control and NL2shRNA-
transfected neurons (Figure 6F; INa+, p > 0.9; IK+, p > 0.2,
Two-way ANOVA).
Considering the specific targeting of NL2 to GABAergic
synapses [14], the reduction in mEPSC frequency after
NL2 knockdown is not easy to interpret. Since NL2 is not
directly localized at glutamatergic synapses, it is possible
that a different protein might mediate the effect of NL2
on glutamatergic synapses. Interestingly, KCC2 has re-
cently been shown to modulate dendritic spines and
AMPA receptor diffusion through interaction with cyto-
skeleton proteins [28,29]. Our above results suggest that
KCC2 may be a novel downstream effector of NL2. We
therefore hypothesized that NL2 may indirectly regulate
glutamatergic synapses through the mediation of KCC2.
To test this hypothesis, we examined the effect of NL2
and KCC2 on dendritic spine morphogenesis in mature
neurons (15 DIV) (Figure 7). Consistent with the elec-
trophysiology data, knockdown of NL2 significantly re-
duced dendritic spines compared to the GFP controls
(Figure 7A-B). Interestingly, coexpression of KCC2
with NL2shRNA significantly rescued dendritic spines
(Figure 7C). The dendritic spines were confirmed with
Figure 6 Neuroligin-2 regulates both GABAergic and glutamatergic synapse formation. A-B, Sample traces showing mIPSCs (A) and
mEPSCs (B) from 10–12 DIV control and NL2shRNA-transfected neurons. C, Bar graphs showing the frequency of mIPSCs (left Y-axis) and mEPSCs
(right Y-axis). n = 10 neurons per group, *p < 0.05, **p < 0.01, unpaired Student’s t-test. D-E, Sample traces showing whole-cell sodium currents
(D) and potassium currents (E) in response to depolarizing voltage steps. F, I-V plot of the mean amplitude of sodium and potassium currents in
control (n = 7) and NL2shRNA-transfected neurons (n = 9).
Figure 7 Neuroligin-2 regulates dendritic spines through KCC2. A-C, Representative images showing dendritic spines in neurons (15 DIV)
transfected with GFP (A), GFP-NL2shRNA (B), or GFP-NL2shRNA + KCC2 (C). Scale bar, 20 μm. D, Enlarged inlets in A-C showing dendritic spines
(green) overlaid with glutamatergic presynaptic terminals labeled by vGlut1 (red). Scale bar, 5 μm. E, Quantification of dendritic spine numbers
per 20 μm in neurons expressing GFP, GFP-NL2shRNA, or GFP-NL2shRNA + KCC2. n = 11 per group. F, Bar graphs showing somatic KCC2
immunofluorescence intensity: control neurons, 153 ± 9, n = 17; GFP-NL2shRNA transfected neurons, 88 ± 14, n = 11; GFP-NL2shRNA + KCC2
transfected neurons, 168 ± 13, n = 9. a.u., arbitrary unit. G, Bar graphs showing the frequency of mIPSCs (n = 9 per group; left Y-axis) and mEPSCs
(n = 11 per group; right Y-axis). mIPSCs: Control, 0.58 ± 0.14 Hz; GFP-NL2shRNA, 0.02 ± 0.01 Hz; GFP-NL2shRNA + KCC2, 0.03 ± 0.02 Hz. mEPSCs:
Control, 2.55 ± 0.42 Hz; GFP-NL2shRNA, 0.12 ± 0.03 Hz; GFP-NL2shRNA + KCC2, 1.07 ± 0.22 Hz. *p < 0.05, ***p < 0.001, n.s., not significant,
one-way ANOVA.
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Figure 8 Graphic summary of major findings and significance.
A, Working model illustrating multiple changes induced by
knockdown of NL2, including reduced GABAergic synapses, reduced
glutamatergic synapses, and reduced KCC2 expression, which results
in increased intracellular Cl- concentration and more excitatory
GABA function. B, Schematic drawing illustrating NL2 as a central
player in regulating the excitation and inhibition balance in
the brain.
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(Figure 7D). Quantitatively, the spine density in con-
trol neurons transfected with GFP alone was 10 ± 1
per 20 μm, and decreased to 4 ± 1 per 20 μm after
transfection with GFP-NL2shRNA, but rescued to 9 ± 1
per 20 μm when KCC2 was coexpressed with GFP-
NL2shRNA (Figure 7E). Knockdown of NL2 in mature
neurons also significantly decreased KCC2 expression,
and KCC2 co-transfection with NL2shRNA effectively res-
cued the KCC2 level (Figure 7F). Moreover, when KCC2
was coexpressed with GFP-NL2shRNA, it partially res-
cued the decrease of mEPSC frequency, but mIPSCs were
not rescued (Figure 7G). These data suggest that NL2 dir-
ectly regulates GABAergic synapse formation, while indir-
ectly regulate glutamatergic synapse formation through
KCC2.
Discussion
In this study, we report a novel function of neuroligin-2
in regulating KCC2 and GABA functional switch in cor-
tical neurons. This is supported by several lines of evi-
dences: 1) Knockdown of NL2 induced a significant
decrease of the expression of KCC2, but not NKCC1; 2)
Overexpressing and knockdown of NL2 caused negative
and positive shift of EGABA, respectively; 3) After knock-
down of NL2, GABA application induced large Ca2+ in-
flux and even action potentials, indicating an excitatory
action; 4) The decrease of KCC2 expression and GABA
functional changes after knockdown of NL1-3 were res-
cued selectively by shRNA-proof NL2*, but not NL1*.
Therefore, KCC2 is specifically regulated by NL2. We
further demonstrate that NL2 may also modulate
glutamatergic transmission and dendritic spines through
the regulation of KCC2. Therefore, knockdown of NL2
will decrease GABAergic synapses, reduce glutamatergic
synapses, and make GABA function more excitatory
(summarized in Figure 8A). These novel findings sup-
port a central role of NL2 in governing the delicate bal-
ance between GABAergic and glutamatergic functions
(Figure 8B).
Classical function of neuroligin-2 in GABAergic
synaptogenesis
Neuroligins and their presynaptic binding partner neurexins
are important trans-synaptic cell adhesion molecules
that play a critical role in synaptogenesis [12,30,31]. The
synaptogenic effect of neuroligins was demonstrated by
their potent induction of presynaptic differentiation
when expressed in non-neuronal cells [16,20,32,33]. The
NL1-3 triple knockout in vivo and acute NL1-3 knockdown
by shRNAs in vitro both showed significant deficits in
synaptic transmission [15,34]. It was later found that
neuroligins might also play a role in synaptic validation
and plasticity [35,36], possibly through a trans-synapticfeedback [37,38]. Most recent studies have revealed that
NL1 may be cleaved by matrix metalloproteinases in an
activity-dependent manner, which regulates glutamatergic
synaptic transmission [39,40]. It will be interesting to inves-
tigate whether other NLs could also be cleaved and how
the cleavage process regulates synaptic functions.
We have previously demonstrated that overexpression of
NL2 with GABAA receptors in HEK cells can induce fully
functional GABAergic innervations from surrounding neu-
rons [20]. We have also identified a novel loss-of-function
mutation of NL2 (R215H) from human schizophrenic patient,
which is incapable of inducing GABAergic innervations [21].
In the current study, we further demonstrate that knockdown
of NL2 significantly reduced GABAergic synaptogenesis, con-
sistent with previous studies [15,41]. The function of NL2 in
regulating GABAergic synapse formation is likely mediated
by interactions with scaffolding proteins like gephyrin and
collybistin [42]. All these studies are consistent with the role
of neuroligin-2 as a cell adhesion molecule to regulate
GABAergic synapse formation and plasticity.
Novel function of neuroligin-2 in regulating KCC2 and
GABA functional switch
The most surprising finding of this work is the regula-
tion of KCC2 by NL2. After knockdown of NL2, the
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tested whether this might be caused by an off-target ef-
fect of the shRNAs, but coexpression of NL2shRNA
with KCC2 in HEK cells showed no effect on the expres-
sion of KCC2 at all. Moreover, the shRNA-proof NL2*,
but not NL1*, rescued the KCC2 expression, suggesting
a NL2-specific regulation of KCC2. Similar to previously
reported knockdown of KCC2 [24], we discovered that
the GABA reversal potential was shifted to more
depolarized level after NL2 knockdown. Moreover, after
NL2 knockdown, bath application of GABA induced
large Ca2+ influx and even triggered action potentials.
These results discover a novel function of NL2 in regu-
lating KCC2 and GABA functional switch. The regula-
tion of KCC2 by NL2 suggests that the time-course of
GABAergic synaptogenesis and GABA functional switch
are tightly coordinated by NL2.
KCC2 is a Cl- transporter with a major function in
controlling intracellular Cl- concentration and therefore
playing an important role in determining whether GABA
function is excitatory or inhibitory [43]. The regulation
of KCC2 by NL2 greatly expands the function of NL2
beyond its classical role as a cell adhesion molecule.
Since both NL2 and KCC2 are transmembrane proteins,
we investigated whether NL2 directly interacts with
KCC2. Our co-immunoprecipitation experiments in
HEK cells and mouse brain lysate suggest a lack of direct
interaction between NL2 and KCC2. However, we can-
not exclude the possibility that NL2 may indirectly inter-
act with KCC2 through other mediating proteins, such
as gephyrin or GABAA receptors, since overexpressed
HA-NL2 showed partial colocalization with KCC2. NL2
may also regulate KCC2 activity through a variety of
pathways, such as transcriptional regulation, phosphoryl-
ation, membrane trafficking, and oligomerization [44].
Since both NL2 and KCC2 regulate GABA functions,
we tested whether the regulation of KCC2 by NL2 may
be dependent upon GABAA receptor activation. Our
pharmacological experiments with BIC and TTX dem-
onstrated that developmental KCC2 up-regulation and
GABA functional switch are independent of GABAA re-
ceptor activation, which is in agreement with previous
studies [27,45]. What may be responsible for KCC2 up-
regulation during neuronal development? Our new find-
ings suggest that KCC2 may be regulated by NL2, a cell
adhesion molecule that expresses early during develop-
ment. Indeed, we found that NL2 expression precedes
that of KCC2 in vivo in early postnatal period, consistent
with previous studies reporting that NL2 expression was
first detected at embryonic day 16 while KCC2 was first
detected at postnatal day 1 [14,24].
Our discovery of the NL2 regulation of KCC2 makes it
easy to connect some interesting findings previously
reported by different labs that are seemingly unrelated.For example, overexpression of NL2 in cerebellar granule
cells has been shown to accelerate GABAergic synapse
maturation by promoting the switch of GABAA receptor
α3 subunit to α1 subunit during early development [41].
Interestingly enough, overexpression of KCC2 was also
found to accelerate this switch in cerebellar granule cells
[46]. Our finding that NL2 regulates KCC2 may explain
why NL2 and KCC2 both showed similar functions in pro-
moting α subunit switch, although other links may also be
possible. Therefore, NL2 is a chief conductor in orches-
trating a variety of GABA functions including GABAergic
synapse formation, GABA functional switch, and GABAA
receptor maturation.
Neuroligin-2 regulates glutamatergic synapses through
KCC2
Given the fact that NL2 is mainly localized at GABAergic
synapses [14], it is initially puzzling that knockdown of
NL2 not only reduced GABAergic synapses, but also re-
duced glutamatergic synapses. The original report using
the same NL2shRNA also showed reductions in both
glutamatergic and GABAergic synapses [15]. Interestingly,
NL2 overexpression increased both glutamatergic and
GABAergic synapse formation [15,17]. On the other hand,
it has been shown that GABAergic, but not glutamatergic,
transmission was decreased in NL2 knockout mice [42].
Such discrepancy between in vitro and in vivo data regard-
ing the role of NL2 at glutamatergic synapses could be
due to the difference between global knockout and
shRNA-mediated knockdown. A recent study demon-
strated that the transcellular differences in the relative
amounts of NL1, rather than the absolute NL1 amount,
governs the number of glutamatergic synapses in vivo
[47]. Nevertheless, how NL2 might regulate glutamatergic
synapses is not very clear.
KCC2 has been found to regulate dendritic spines.
Specifically, Rivera and colleagues first reported that
neurons from KCC2 knockout mice showed abnormally
long dendritic protrusions and low frequency of mEPSCs
[29]. Similarly, knockdown of KCC2 in developing neu-
rons decreased the frequency of glutamatergic events
[28]. KCC2 has also been shown to regulate the diffusion
of AMPA receptors in dendritic spines [28]. Here, we
demonstrated that NL2 regulates KCC2, raising a poten-
tial link between NL2 and glutamatergic synapses
through KCC2. Indeed, overexpression of KCC2 to-
gether with NL2shRNA was able to rescue decreased
glutamatergic synapses induced by NL2 knockdown,
suggesting that KCC2 is likely the mediator of NL2 regu-
lation of glutamatergic synapses. Therefore, NL2 not
only regulates GABAergic synapses, but also regulates
glutamatergic synapses through regulating KCC2, mak-
ing NL2 a central player in balancing GABAergic and
glutamatergic functions in the brain.
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To conclude, our data discovered a novel function of
NL2 in regulating KCC2 and consequently affecting
GABA functional switch as well as glutamatergic synap-
ses. This finding extends the function of NL2 beyond its
classical role in cell adhesion, and put NL2 in a central
position in coordinating GABAergic synaptogenesis with
GABA functional switch, and in balancing GABAergic
and glutamatergic functions. We propose that NL2 may
function as a master regulator of the delicate excitation-
inhibition balance in the brain, and NL2 may be a novel




Primary mouse cortical neurons were cultured as previ-
ously described [11]. Briefly, cerebral cortices of new-
born C57BL/6 mice of either sex were dissociated and
plated on a monolayer of cortical astrocytes at a density
of 8,000-12,000 cells/cm2 in 24-well plates. Culture
medium contained MEM (500 ml, Invitrogen), 5% FBS
(HyClone), 10 ml B-27 supplement (Invitrogen), 100 mg
NaHCO3, 20 mM D-glucose, 2 mM Glutamax (Invitrogen),
and 25 units/ml penicillin/streptomycin. Neurons were
maintained at 37°C in a 5% CO2-humidified incubator. All
experiments were repeated in at least three independent
cultures.
Transfection
Calcium-phosphate transfection in cultured neurons was
performed similar to a protocol developed in our labora-
tory [48]. Plasmid at 1 μg each was used for transfection
per well in a 24-well plate. HEK 293T cells were
transfected using polyethylenimine (Polysciences). GFP
or mCherry was coexpressed to identify transfected cells.
Plasmids
NLmiR with IRES GFP or mCherry, HA-tagged shRNA-
proof mouse NL1* and rat NL2* with IRES mCherry
were generously provided by Dr. Roger Nicoll (University
of California at San Francisco, San Francisco, CA).
HA-tagged WT mouse NL2 and EGFP-NL2shRNA were
provided by Dr. Peter Scheiffele (University of Basel, Basel,
Switzerland). A non-tagged NL2shRNA was generated
by cutting off EGFP with restriction enzymes. NLmiR
and NL2shRNA have been characterized previously
[15,22]. The NL2 target sequence of NL2shRNA and
NLmiR is identical (ATGGAGCAAGTTCAACAGCAA)
and conserved in mouse and rat. Rat KCC2 (pIRES2-EGFP)
was provided by Dr. Yun Wang (Fudan University,
Shanghai, China). mCherry (pEGFP-C1) was provided
by Dr. Yingwei Mao (Pennsylvania State University,
University Park, PA).Immunostaining and imaging analysis
Neurons were fixed in 4% paraformaldehyde for 8 min,
permeabilized with 0.2% Triton X-100 for 5 min, and
blocked with 5% normal donkey/goat serum for 30 min.
Primary antibodies in blocking solution were incubated
overnight at 4°C. Dylight-conjugated secondary anti-
bodies (Jackson ImmunoResearch) were incubated at
room temperature for 45 min. Following antibodies were
used: KCC2 (07–432, Millipore), HA (sc-7392, Santa
Cruz Biotechnology), MAP2 (ab5392, Abcam), NKCC1
(T4, Developmental Studies Hybridoma Bank), vGlut1
(135302, Synaptic Systems), GFP (ab13970, Abcam).
Confocal images were collected on an Olympus FV1000
confocal microscope. For the quantification of HA,
KCC2, and NKCC1 immunostaining, neuronal soma was
selected and the mean intensity (0–255) was analyzed by
ImageJ software. For spine density analysis, two second-
ary dendritic segments of 20 μm each were analyzed per
neuron.
Electrophysiology
The electrophysiological experiments were performed as
previously described [21,49]. Briefly, Multiclamp 700A
amplifier and pClamp software (Molecular Devices) were
used for acquiring data (sampling at 10 kHz and filtered
at 1 kHz). Neurons were continually perfused with bath
solution (in mM): 128 NaCl, 30 glucose, 25 HEPES, 5
KCl, 2 CaCl2 and 1 MgCl2 (320 mOsm, adjusted to pH
7.3 with NaOH). Pipette solution contained (in mM):
147 KCl, 5 Na2-phosphocreatine, 2 EGTA, 10 HEPES, 2
MgATP, 0.3 Na2GTP (300 mOsm adjusted to pH 7.3
with KOH). Gramicidin (40 μg/ml, Sigma) was included
in the pipette solution for perforated patch recording
[26]. A Picospritzer (Parker Instrumentation) was used
to eject GABA directly to neuronal soma through a fine
pipette (~2 μm tip). In whole-cell patch clamp mode
(holding at −70 mV), mEPSCs were recorded in the
presence of TTX (0.5 μM) and BIC (20 μM); mIPSCs
were recorded in the presence of TTX (0.5 μM) and
DNQX (10 μM).
Immunoblot
HEK 293T cells in 6-well plates were transfected using
polyethylenimine and total protein lysate was harvested
after 2–3 days in lysis buffer (20 mM HEPES, 1% Triton
X-100, 0.1 mM EDTA, 2 mM CaCl2, 1mM MgCl2 and 50
mM NaCl with PMSF, protease and phosphatase inhibi-
tors, pH 7.3 with NaOH). For cultured neurons, 2 wells
from a 24-well plate were lysised at each time point. For
mouse cortical proteins, cortices were dissected out and
homogenized. After 2 hr rotation at 4°C, supernatant was
harvested by centrifugation (12,000 g, 30 min). Protein
concentration was measured by Bradford Protein Assay
Kit (Thermo Scientific Pierce Protein Biology Products).
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and 1% β-mercaptoethanol at 95°C (for NL2) or 50°C (for
KCC2) for 15 min before resolved in 10% SDS-PAGE and
transferred to PVDF membrane. Primary antibodies in-
cluding rabbit anti-KCC2 (07–432, Millipore), rabbit
anti-NL2 (129202, Synaptic Systems), mouse anti-HA
(sc-7392, Santa Cruz Biotechnology) and mouse anti-
actin (612656, BD Transduction Laboratories) together
with HRP-conjugated secondary antibodies (Abcam)
were used. Immunoblot band intensities were mea-
sured with ImageJ software.
Co-immunoprecipitation
HEK 293T cells in 10-cm dish were transfected and total
protein lysate was harvested after 2 days in Pierece IP
buffer (Thermo Scientific) with protease and phosphat-
ase inhibitors. Protein lysate was pre-cleaned by incuba-
tion with Dynabeads M-280 sheep anti-mouse IgG
(11201D, Invitrogen) for 2 hr at 4°C. About 2 mg protein
lysate was then incubated with Dynabeads and 2 μg nor-
mal mouse IgG (PP54, Millipore) or mouse anti-HA
antibodies overnight at 4°C. After washing with IP buffer
and PBS, the immunoprecipitated proteins were eluted
by NuPAGE LDS sample buffer (Invitrogen). Protein lys-
ate from 2–3 month old mouse brain was processed fol-
lowing the same protocol with Dynabeads M-280 sheep
anti-rabbit IgG (11203D, Invitrogen). Normal rabbit IgG
(PP64, Millipore) was used as control.
Calcium imaging
Cells were incubated in 2.5 μM Fura-2 AM (Invitrogen)
for 45 min at 37°C and washed for 15 min in bath solu-
tion. Coverslips were transferred to a perfusion chamber
mounted on a Nikon TE-2000-S inverted microscope
with a 20× objective and imaged with a 340/380 nm
transmittance filter set (Chroma Technology). SimplePCI
(HCImage, Hamamatsu) was used to measure the ratio
of 340/380 fluorescence signal in neuronal soma. Sister
coverslips from 3–4 independent cultures were taken for
imaging at 3–4 time points. mCherry was coexpressed
to identify transfected cells in all calcium imaging exper-
iments. All recordings were done in the presence of
DNQX (10 μM) to block AMPA receptor activations.
The threshold of a significant Ca2+ response was set as
10 times of baseline standard deviation.
Statistical analysis
Unpaired Student’s t-test was used for comparisons be-
tween two groups. One-way ANOVA with Bonferroni
multiple comparisons was used for comparisons between
multiple groups. Two-way ANOVA with Bonferroni
multiple comparisons was used for comparisons between
multiple time points and groups. GraphPad Prism
(GraphPad Software) was used for all statistical analysis.Data were shown as mean ± standard error in all bar
graphs.
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